{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:28:20Z","timestamp":1774531700403,"version":"3.50.1"},"reference-count":166,"publisher":"Informa UK Limited","issue":"234","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Scandinavian Journal of Gastroenterology"],"published-print":{"date-parts":[[2001,1]]},"DOI":"10.1080\/003655201753265082","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T11:29:43Z","timestamp":1027682983000},"page":"29-40","source":"Crossref","is-referenced-by-count":148,"title":["The Bacterial Flora in Inflammatory Bowel Disease: Current Insights in Pathogenesis and the Influence of Antibiotics and Probiotics"],"prefix":"10.1080","volume":"36","author":[{"given":"R. K.","family":"Linskens","sequence":"first","affiliation":[{"name":"Depts. of Gastroenterology and Medical Microbiology, Academic Hospital Vrije Universiteit Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X. W.","family":"Huijsdens","sequence":"additional","affiliation":[{"name":"Depts. of Gastroenterology and Medical Microbiology, Academic Hospital Vrije Universiteit Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. H. M.","family":"Savelkoul","sequence":"additional","affiliation":[{"name":"Depts. of Gastroenterology and Medical Microbiology, Academic Hospital Vrije Universiteit Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. M. J. E.","family":"Vandenbroucke-Grauls","sequence":"additional","affiliation":[{"name":"Depts. of Gastroenterology and Medical Microbiology, Academic Hospital Vrije Universiteit Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. G. M.","family":"Meuwissen","sequence":"additional","affiliation":[{"name":"Depts. of Gastroenterology and Medical Microbiology, Academic Hospital Vrije Universiteit Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"crossref","unstructured":"Warren JR Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;i:1273\u20135.","DOI":"10.1016\/S0140-6736(83)92719-8"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)91795-6"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199207303270501"},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","unstructured":"Drasar BS Shiner M Mcleod GM. Studies on the intestinal flora. 1. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons. Gastroenterology 1969;56: 71\u20139.","DOI":"10.1016\/S0016-5085(69)80067-3"},{"key":"e_1_2_1_6_1","unstructured":"Gorbach SL Levitan R. Intestinal flora in health and gastrointestinal diseases. In: Glass GBJ editor. Progress in gastroenterology vol. 2. New York: Grune and Stratton; 1970. p. 252\u201375."},{"key":"e_1_2_1_7_1","first-page":"856","article-title":"Weinstein L","volume":"53","author":"Gorbach SL","year":"1967","unstructured":"Gorbach SL, Plaut AG, Weinstein L. Studies of intestinal microflora. II. Microorganisms of the small intestine and their relations to oral and fecal flora. Gastroenterology 1967;53: 856\u201367.","journal-title":"Studies of intestinal microflora. II. Microorganisms of the small intestine and their relations to oral and fecal flora. Gastroenterology"},{"key":"e_1_2_1_8_1","first-page":"812","article-title":"Studies on the intestinal flora","volume":"10","author":"Drasar BS","year":"1969","unstructured":"Drasar BS, Shiner M. Studies on the intestinal flora. II. Bacterial flora of the small intestine in patients with gastrointestinal disorders. Gut 1969;10:812\u20139.","journal-title":"II. Bacterial flora of the small intestine in patients with gastrointestinal disorders. Gut"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(71)80039-2"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(79)90309-X"},{"key":"e_1_2_1_11_1","unstructured":"Savage DC. Interactions between the host and its microbes. In: Clarke RTJ Bauchop T editors. Microbial ecology of the gut. New York: Academic Press; 1977. p. 277\u2013310."},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/23.11.1457"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.16.4.318"},{"key":"e_1_2_1_14_1","unstructured":"Drasar BS Hill MJ. Human intestinal microflora. New York: Academic Press; 1974."},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(19)34121-6"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(84)90606-1"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198207083070203"},{"issue":"1","key":"e_1_2_1_18_1","first-page":"5","article-title":"Onnela T","volume":"41","author":"Salminen S","year":"1995","unstructured":"Salminen S, Isolauri E, Onnela T. Gut flora in normal and disordered states. Chemotherapy 1995;41 Suppl 1:5\u201315.","journal-title":"Gut flora in normal and disordered states. Chemotherapy"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(77)80836-6"},{"key":"e_1_2_1_20_1","first-page":"3778","article-title":"Diet and the human intestinal bacterial flora","volume":"41","author":"Hill MJ","year":"1981","unstructured":"Hill MJ. Diet and the human intestinal bacterial flora. Cancer Res 1981;41:3778\u201380.","journal-title":"Cancer Res"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1128\/jb.83.5.968-974.1962"},{"key":"e_1_2_1_22_1","first-page":"593","article-title":"Shooter R","volume":"4","author":"Cooke EM","year":"1969","unstructured":"Cooke EM, Ewins SP, Shooter R. The changing fecal population of E. coli in hospital medical patients. Br Med J 1969;4:593\u20135.","journal-title":"The changing fecal population of E. coli in hospital medical patients. Br Med J"},{"key":"e_1_2_1_23_1","unstructured":"Savage DC. Colonization by and survival of pathogenic bacteria on intestinal mucosal surfaces. In: Britton G Marshall KC editors. Adsorption of microorganisms to surfaces. New York: John Wiley; 1980. p. 175\u2013205."},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0022172400021653"},{"key":"e_1_2_1_25_1","doi-asserted-by":"crossref","unstructured":"Rolfe R. Colonization resistance. In: Mackie RI White BA Isaacson RE editors. Gastrointestinal microbiology. Gastrointestinal microbes and host interactions. New York: Chapman and Hall; 1996. p. 501\u201336.","DOI":"10.1007\/978-1-4757-0322-1_13"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/27.12.1450"},{"key":"e_1_2_1_27_1","first-page":"S33","article-title":"Holdeman LV","volume":"31","author":"Moore WEC","year":"1978","unstructured":"Moore WEC, Cato EP, Holdeman LV. Some current concepts in intestinal bacteriology. Am J Clin Nutr 1978;31:S33\u201342.","journal-title":"Some current concepts in intestinal bacteriology. Am J Clin Nutr"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.mi.31.100177.000543"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/13.4.721"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(91)90211-3"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)91563-9"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00393670"},{"key":"e_1_2_1_33_1","first-page":"335","article-title":"Burnham WR, Lennard-Jones JE","volume":"18","author":"Hudson MJ","year":"1984","unstructured":"Hudson MJ, Hill MJ, Elliott PR, Berghouse LM, Burnham WR, Lennard-Jones JE. The microbial flora of the rectal mucosa and faeces of patients with Crohn\u2019s disease before and during antimicrobial chemotherapy. J Med Microbiol 1984;18:335\u201345.","journal-title":"The microbial flora of the rectal mucosa and faeces of patients with Crohn\u2019s disease before and during antimicrobial chemotherapy. J Med Microbiol"},{"key":"e_1_2_1_34_1","first-page":"183","article-title":"Jarnerot G","volume":"16","author":"Danielsson D","year":"1981","unstructured":"Danielsson D, Kjellander J, Jarnerot G. The effect of metronidazole and sulfasalazine on the fecal flora in patients with Crohn\u2019s disease. Scand J Gastroenterol 1981;16:183\u201392.","journal-title":"The effect of metronidazole and sulfasalazine on the fecal flora in patients with Crohn\u2019s disease. Scand J Gastroenterol"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-8-4-491"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-36-2-96"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-46-1-85"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70393-8"},{"key":"e_1_2_1_39_1","unstructured":"Chadwick VS Anderson RP. Microorganisms and their products in inflammatory bowel disease. In: McDermott RP Stimpson WF editors. Inflammatory bowel disease. New York: Elsevier; 1992. p. 241\u201358."},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.me.35.020184.000523"},{"key":"e_1_2_1_41_1","unstructured":"Neutra MR Giannasca PJ et al. M cells and microbial pathogens. In: Blaser MJ Smith PD Ravdin JI Greenberg JB Guerrant RL editors. Infections of the gastrointestinal tract. New York: Raven Press; 1995. p. 163\u201378."},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-105-6-883"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8553(21)00040-6"},{"key":"e_1_2_1_44_1","unstructured":"Sartor RB. Microbial factors in the pathogenesis of Crohn\u2019s disease ulcerative colitis and experimental intestinal inflammation. In: Kirsner JB editor. Inflammatory bowel disease 5th ed. Philadelphia: W. B. Saunders; 2000. p. 153\u201378."},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)30096-7"},{"key":"e_1_2_1_46_1","doi-asserted-by":"crossref","unstructured":"Ward DM Weller R Bateson MM. 16S rRNA sequences reveal numerous uncultured microorganisms in a natural community. Nature 1990;345: 63\u20135.","DOI":"10.1038\/345063a0"},{"key":"e_1_2_1_47_1","first-page":"141","article-title":"In situ PCR","volume":"71","author":"Long AA","year":"1997","unstructured":"Long AA, Komminoth P. In situ PCR. An overview. Meth Mol Biol 1997;71:141\u201361.","journal-title":"An overview. Meth Mol Biol"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-294X.1995.tb00255.x"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1000669317571"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1101\/gr.6.10.986"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.2000.00656.x"},{"key":"e_1_2_1_52_1","first-page":"391","article-title":"Koutroubakis I, von Blomberg BME, et al","volume":"103","author":"Bouma G","year":"1996","unstructured":"Bouma G, Xia B, Crusius JBA, Bioque G, Koutroubakis I, von Blomberg BME, et al. Distribution of four polymorphisms in the tumor necrosis factor genes in patients with inflammatory bowel disease. Clin Exp Immunol 1996;103:391\u20136.","journal-title":"Distribution of four polymorphisms in the tumor necrosis factor genes in patients with inflammatory bowel disease. Clin Exp Immunol"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/003655299750025147"},{"key":"e_1_2_1_54_1","doi-asserted-by":"crossref","unstructured":"Bouma G Poen AC Garcia-Gonzalez MA Schreuder GMT Felt-Bersma RJF Meuwissen SGM et al. HLA-DR3B1*03 but not the TNFa-308 promoter gene polymorphism protection against fistulising Crohn\u2019s disease. Immunogenetics 1998;47: 451\u20135.","DOI":"10.1007\/s002510050382"},{"key":"e_1_2_1_55_1","first-page":"395","article-title":"Tytgat GNJ, van Deventer SJH","volume":"45","author":"Stokkers PCF","year":"1999","unstructured":"Stokkers PCF, Reitsma PH, Tytgat GNJ, van Deventer SJH. HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut 1999;45:395\u2013401.","journal-title":"HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut"},{"key":"e_1_2_1_56_1","first-page":"381","article-title":"Environmental risk factors in inflammatory bowel disease","volume":"43","author":"Koutroubakis I","year":"1996","unstructured":"Koutroubakis I, Manousos ON, Meuwissen SGM, Pena AS. Environmental risk factors in inflammatory bowel disease. Hepato-Gastroenterol 1996;43:381\u201393.","journal-title":"Hepato-Gastroenterol"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70381-6"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90719-6"},{"key":"e_1_2_1_59_1","first-page":"144","article-title":"Green JT","volume":"43","author":"Thomas GA","year":"1998","unstructured":"Thomas GA, Rhodes J, Green JT. Inflammatory bowel disease and smoking\u2014a review. Am J Gastroenterol 1998;43:144\u20139.","journal-title":"Inflammatory bowel disease and smoking\u2014a review. Am J Gastroenterol"},{"key":"e_1_2_1_60_1","first-page":"377","article-title":"Brummer RJM, van de Kruys MA, Muris WJ, Bergers JM, et al","volume":"113","author":"Russel MGWM","year":"1997","unstructured":"Russel MGWM, Dorant E, Brummer RJM, van de Kruys MA, Muris WJ, Bergers JM, et al. Appendectomy and the risk of developing ulcerative colitis or Crohn\u2019s disease: result of a large case-control study. Gastroenterology 1997;113:377\u201382.","journal-title":"Appendectomy and the risk of developing ulcerative colitis or Crohn\u2019s disease: result of a large case-control study. Gastroenterology"},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365528708991950"},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02088342"},{"key":"e_1_2_1_63_1","first-page":"549","article-title":"Walker-Smith JA","volume":"98","author":"Kangro HO","year":"1990","unstructured":"Kangro HO, Chong SK, Hardiman A, Heath RB, Walker-Smith JA. A prospective study of viral and mycoplasma infections in chronic inflammatory bowel disease. Gastroenterology 1990; 98:549\u201353.","journal-title":"A prospective study of viral and mycoplasma infections in chronic inflammatory bowel disease. Gastroenterology"},{"key":"e_1_2_1_64_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6140.801-a"},{"key":"e_1_2_1_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(91)90487-6"},{"key":"e_1_2_1_66_1","unstructured":"Miner PB. Factors influencing the relapse of patients with inflammatory bowel disease. Am J Gastroenterol 1997;92:1S\u20134S."},{"key":"e_1_2_1_67_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.159.1.44"},{"key":"e_1_2_1_68_1","first-page":"91","article-title":"T cell receptor-alpha-beta-defi cient mice fail to develop colitis in the absence of a microbial environment","volume":"150","author":"Dianda L","year":"1997","unstructured":"Dianda L, Hanby AM, Wright NA, Sebesteny A, Hayday AC, Owen MJ. T cell receptor-alpha-beta-defi cient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol 1997;150:91\u20137.","journal-title":"Am J Pathol"},{"key":"e_1_2_1_69_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365529309096052"},{"key":"e_1_2_1_70_1","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-199703000-00006"},{"key":"e_1_2_1_71_1","unstructured":"Morgan KL. Johne\u2019s and Crohn\u2019s. Chronic inflammatory bowel disease of infectious aetiology? Lancet 1987;i:1017\u20139."},{"key":"e_1_2_1_72_1","first-page":"1073","article-title":"Possible role of mycobacteria in inflammatory bowel disease","volume":"29","author":"Chiodini RJ","year":"1984","unstructured":"Chiodini RJ, van Kruiningen HJ, Thayer Jr WR, Merkal RS, Coutu JA. Possible role of mycobacteria in inflammatory bowel disease. An unclassifi ed mycobacterium species isolated from patients with Crohn\u2019s disease. Dig Dis Sci 1984;29: 1073\u20139.","journal-title":"An unclassifi ed mycobacterium species isolated from patients with Crohn\u2019s disease. Dig Dis Sci"},{"key":"e_1_2_1_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1992.tb05874.x"},{"key":"e_1_2_1_74_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.34.3.371"},{"key":"e_1_2_1_75_1","first-page":"43","article-title":"Walker-Smith JA, Tabaqchali S","volume":"31","author":"Tanaka K","year":"1991","unstructured":"Tanaka K, Wilks M, Coates PJ, Farthing MJ, Walker-Smith JA, Tabaqchali S. Mycobacterium paratuberculosis and Crohn\u2019s disease. Gut 1991;31:43\u20135.","journal-title":"Mycobacterium paratuberculosis and Crohn\u2019s disease. Gut"},{"key":"e_1_2_1_76_1","unstructured":"Fidler HM McFadden. Infective agents\u2014mycobacteria. In: Kirsner JB Shorter RG editors. Inflammatory bowel disease 4th ed. Baltimore: Williams & Wilkins; 1995. p. 125\u201331."},{"key":"e_1_2_1_77_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.42.4.497"},{"key":"e_1_2_1_78_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01641423"},{"key":"e_1_2_1_79_1","doi-asserted-by":"publisher","DOI":"10.1128\/iai.28.2.516-523.1980"},{"key":"e_1_2_1_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90687-8"},{"key":"e_1_2_1_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(84)90084-2"},{"key":"e_1_2_1_82_1","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200002000-00005"},{"key":"e_1_2_1_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890390415"},{"key":"e_1_2_1_84_1","first-page":"28","article-title":"Shivanada S","volume":"30","author":"Miyamoto H","year":"1995","unstructured":"Miyamoto H, Tanaka T, Kitamoto N, Fukada Y, Shivanada S. Detection of immunoreactive antigen with a monoclonal antibody to measles virus in tissue from patients with Crohn\u2019s disease. J Gastroenterol 1995;30:28\u201333.","journal-title":"Detection of immunoreactive antigen with a monoclonal antibody to measles virus in tissue from patients with Crohn\u2019s disease. J Gastroenterol"},{"key":"e_1_2_1_85_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01333705"},{"key":"e_1_2_1_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91898-8"},{"key":"e_1_2_1_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)04429-7"},{"key":"e_1_2_1_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70062-4"},{"key":"e_1_2_1_89_1","first-page":"473","article-title":"Piracha S","volume":"349","author":"Jones P","year":"1997","unstructured":"Jones P, Fine P, Piracha S. Crohn\u2019s disease and measles. Lancet 1997;349:473.","journal-title":"Crohn\u2019s disease and measles. Lancet"},{"key":"e_1_2_1_90_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.2.211"},{"key":"e_1_2_1_91_1","first-page":"967","article-title":"Cortot A, van Kruiningen HJ, Colombel JF","volume":"346","author":"Touze Y","year":"1995","unstructured":"Touze Y, Dubucquoi S, Cortot A, van Kruiningen HJ, Colombel JF. IgM-specific measles-virus antibody in families with a high frequency of Crohn\u2019s disease. Lancet 1995;346: 967.","journal-title":"IgM-specific measles-virus antibody in families with a high frequency of Crohn\u2019s disease. Lancet"},{"key":"e_1_2_1_92_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199707000-00003"},{"key":"e_1_2_1_93_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7126.166"},{"key":"e_1_2_1_94_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.46.2.163"},{"key":"e_1_2_1_95_1","first-page":"19","article-title":"Picket van Ulsen J, Michel MF, Stolze E","volume":"1","author":"Schuller JL","year":"1979","unstructured":"Schuller JL, Veeken IVD, Picket van Ulsen J, Michel MF, Stolze E. Antibodies against Chlamydia of lymphogranuloma-venereum type in Crohn\u2019s disease. Lancet 1979;1:19\u201320.","journal-title":"Antibodies against Chlamydia of lymphogranuloma-venereum type in Crohn\u2019s disease. Lancet"},{"key":"e_1_2_1_96_1","first-page":"1162","article-title":"BJ, O\u2019Morain CA, Levi AJ","volume":"1","author":"Taylor-Robinson D","year":"1979","unstructured":"Taylor-Robinson D, Thomas BJ, O\u2019Morain CA, Levi AJ. Low frequency of chlamydial antibodies in patients with Crohn\u2019s disease and ulcerative colitis. Lancet 1979;1:1162\u20133.","journal-title":"Low frequency of chlamydial antibodies in patients with Crohn\u2019s disease and ulcerative colitis. Lancet"},{"key":"e_1_2_1_97_1","first-page":"25","article-title":"Lennard-Jones JE","volume":"22","author":"Elliott PR","year":"1981","unstructured":"Elliott PR, Forsey T, Darougar S, Treharine JD, Lennard-Jones JE. Chlamydiae and inflammatory bowel disease. Gut 1981; 22:25\u20137.","journal-title":"Chlamydiae and inflammatory bowel disease. Gut"},{"key":"e_1_2_1_98_1","doi-asserted-by":"publisher","DOI":"10.1159\/000233867"},{"key":"e_1_2_1_99_1","first-page":"479","article-title":"Albini B","volume":"92","author":"Knoflach P","year":"1987","unstructured":"Knoflach P, Park BH, Cunningham R, Weiser MM, Albini B. Serum antibodies to cow\u2019s milk proteins in ulcerative colitis and Crohn\u2019s disease. Gastroenterology 1987;92:479\u201385.","journal-title":"Serum antibodies to cow\u2019s milk proteins in ulcerative colitis and Crohn\u2019s disease. Gastroenterology"},{"key":"e_1_2_1_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(76)80394-0"},{"key":"e_1_2_1_101_1","first-page":"196","article-title":"Pennington CR","volume":"27","author":"Barclay GR","year":"1992","unstructured":"Barclay GR, McKenzie H, Pennington J, Parratt D, Pennington CR. The effect of dietary yeast on the activity of stable chronic Crohn\u2019s disease. Scand J Gastroenterol 1992;27:196\u2013200.","journal-title":"The effect of dietary yeast on the activity of stable chronic Crohn\u2019s disease. Scand J Gastroenterol"},{"key":"e_1_2_1_102_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.297.6656.1105"},{"key":"e_1_2_1_103_1","first-page":"1071","article-title":"Holdsworth CD","volume":"33","author":"Giaffer MH","year":"1992","unstructured":"Giaffer MH, Clark A, Holdsworth CD. Antibodies to Saccharomyces cerevisiae in patients with Crohn\u2019s disease and their possible pathogenic importance. Gut 1992;33: 1071\u20135.","journal-title":"Antibodies to Saccharomyces cerevisiae in patients with Crohn\u2019s disease and their possible pathogenic importance. Gut"},{"key":"e_1_2_1_104_1","doi-asserted-by":"crossref","unstructured":"Sendid B Quinton J-F Charrier G Goulet O Cortot A Grandbastien B et al. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn\u2019s disease. Am J Gastroenterol 1998;93: 1306\u201310.","DOI":"10.1111\/j.1572-0241.1998.00415.x"},{"key":"e_1_2_1_105_1","first-page":"47","article-title":"Dawson J","volume":"52","author":"Darroch CJ","year":"1999","unstructured":"Darroch CJ, Barnes RMR, Dawson J. Circulating antibodies to Saccharomyces cerevisiae (baker\u2019 s\/brewers\u2019 yeast) in gastrointestinal disease. J Clin Path 1999;52:47\u201353.","journal-title":"Circulating antibodies to Saccharomyces cerevisiae (baker\u2019 s\/brewers\u2019 yeast) in gastrointestinal disease. J Clin Path"},{"key":"e_1_2_1_106_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.46.1.58"},{"key":"e_1_2_1_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70252-5"},{"key":"e_1_2_1_108_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.19.2.108"},{"key":"e_1_2_1_109_1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800710821"},{"key":"e_1_2_1_110_1","first-page":"1405","article-title":"Escherichia coli","volume":"115","author":"Darfeuille-Michaud A","year":"1998","unstructured":"Darfeuille-Michaud A, Neut C, Barnich N, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn\u2019s disease. Gastroenterology 1998;115: 1405\u201313.","journal-title":"strains in ileal mucosa of patients with Crohn\u2019s disease. Gastroenterology"},{"key":"e_1_2_1_111_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.1999.tb00415.x"},{"key":"e_1_2_1_112_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.51.9.657"},{"key":"e_1_2_1_113_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0022172400069205"},{"key":"e_1_2_1_114_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0022172400069199"},{"key":"e_1_2_1_115_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0022172400069187"},{"key":"e_1_2_1_116_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365528809090179"},{"key":"e_1_2_1_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90663-A"},{"key":"e_1_2_1_118_1","first-page":"29","volume":"4","author":"Janowitz HD","year":"1998","unstructured":"Janowitz HD, Croen EC, Sachar DB. The role of the fecal stream in Crohn\u2019s disease: an historical and analytic review. Inflam Bowel Dis 1998;4:29\u201339.","journal-title":"Sachar DB. The role of the fecal stream in Crohn\u2019s disease: an historical and analytic review. Inflam Bowel Dis"},{"key":"e_1_2_1_119_1","first-page":"262","article-title":"P","volume":"114","author":"D\u2019Haens GR","year":"1998","unstructured":"D\u2019Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P. Early lesions of recurrent Crohn\u2019s disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998;114:262\u20137.","journal-title":"Early lesions of recurrent Crohn\u2019s disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology"},{"key":"e_1_2_1_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70492-5"},{"key":"e_1_2_1_121_1","first-page":"974","article-title":"Antibiotics in inflammatory bowel disease: new choices for an old disease","volume":"89","author":"Spirt MJ","year":"1994","unstructured":"Spirt MJ. Antibiotics in inflammatory bowel disease: new choices for an old disease. Am J Gastroenterol 1994;89:974\u20138.","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_1_122_1","first-page":"43","article-title":"Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis","volume":"89","author":"Mantzaris GJ","year":"1994","unstructured":"Mantzaris GJ, Hatzis A, Kontogiannis P, Triadaphyllou G. Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis. Am J Gastroenterol 1994;89:43\u20136.","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_1_123_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199307000-00005"},{"key":"e_1_2_1_124_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.26.12.1380"},{"key":"e_1_2_1_125_1","first-page":"454","article-title":"A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis","volume":"92","author":"Mantzaris GJ","year":"1997","unstructured":"Mantzaris GJ, Archavlis E, Christoforidis P, Kourtessas D, Amberiadis P, Florakis N, et al. A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis. Am J Gastroenterol 1997;92:454\u20136.","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_1_126_1","first-page":"1210","article-title":"Jewell DP","volume":"27","author":"Chapman RW","year":"1986","unstructured":"Chapman RW, Selby WS, Jewell DP. Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. Gut 1986;27:1210\u20132.","journal-title":"Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. Gut"},{"key":"e_1_2_1_127_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1990.tb00456.x"},{"key":"e_1_2_1_128_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1993.tb00084.x"},{"key":"e_1_2_1_129_1","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-199802000-00001"},{"key":"e_1_2_1_130_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026648812439"},{"key":"e_1_2_1_131_1","first-page":"518","article-title":"Life-threatening complications of IBD: How to handle fulminant colitis and toxic megacolon","volume":"13","author":"Stein R","year":"1998","unstructured":"Stein R, Hanauer SB. Life-threatening complications of IBD: How to handle fulminant colitis and toxic megacolon. J Crit Illness 1998;13:518\u201321.","journal-title":"J Crit Illness"},{"key":"e_1_2_1_132_1","first-page":"1193","article-title":"Nicholls RJ","volume":"39","author":"Madden MV","year":"1994","unstructured":"Madden MV, McIntyre AS, Nicholls RJ. Double-blind crossover trial of metronidazole versus placebo in chronic remitting pouchitis. Dig Dis Sci 1994;39:1193\u20136.","journal-title":"Double-blind crossover trial of metronidazole versus placebo in chronic remitting pouchitis. Dig Dis Sci"},{"key":"e_1_2_1_133_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00553.x"},{"key":"e_1_2_1_134_1","first-page":"A650","article-title":"Bacterial dysbiosis in the pathogenesis of ileal pouchitis","volume":"106","author":"Becker JM","year":"1994","unstructured":"Becker JM, Onderdonk AB. Bacterial dysbiosis in the pathogenesis of ileal pouchitis. Gastroenterology 1994;106:A650.","journal-title":"Gastroenterology"},{"key":"e_1_2_1_135_1","first-page":"658","volume":"35","author":"JGH Ruseler-van Embden","year":"1994","unstructured":"Ruseler-van Embden JGH, Schouten WR, van Lieshout LMC. Pouchitis: result of microbial imbalance? Gut 1994;35:658\u201364.","journal-title":"Lieshout LMC. Pouchitis: result of microbial imbalance? Gut"},{"key":"e_1_2_1_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90832-X"},{"key":"e_1_2_1_137_1","first-page":"550","article-title":"Ganrot-Norlin K, Hoevels J, et al","volume":"83","author":"Ursing B","year":"1982","unstructured":"Ursing B, Alm T, Barany F, Bergelin I, Ganrot-Norlin K, Hoevels J, et al. A comparative study of metronidazole and sulfasalazine for active Crohn\u2019s disease: the cooperative Crohn\u2019s disease study in Sweden. Gastroenterology 1982;83: 550\u201362.","journal-title":"A comparative study of metronidazole and sulfasalazine for active Crohn\u2019s disease: the cooperative Crohn\u2019s disease study in Sweden. Gastroenterology"},{"key":"e_1_2_1_138_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.32.9.1071"},{"key":"e_1_2_1_139_1","first-page":"328","article-title":"An antibiotic regimen for the treatment of active Crohn\u2019s disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin","volume":"91","author":"Prantera C","year":"1996","unstructured":"Prantera C, Zannoni F, Scribano ML, Berto E, Andreoli A, Kohn A, et al. An antibiotic regimen for the treatment of active Crohn\u2019s disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin. Am J Gastroenterol 1996;91: 328\u201332.","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_1_140_1","first-page":"602","article-title":"Use of antibiotics in the treatment of active Crohn\u2019s disease: experience with metronidazole and ciproxin","volume":"30","author":"Prantera C","year":"1998","unstructured":"Prantera C, Berto E, Scribano ML, Falasco G. Use of antibiotics in the treatment of active Crohn\u2019s disease: experience with metronidazole and ciproxin. Ital J Gastroenterol Hepatol 1998;30:602\u20136.","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"e_1_2_1_141_1","first-page":"53","article-title":"Greenberg GR","volume":"12","author":"Greenbloom SL","year":"1998","unstructured":"Greenbloom SL, Steinhart AH, Greenberg GR. Combination ciprofloxacin and metronidazole for active Crohn\u2019s disease. Can J Gastroenterol 1998;12:53\u20136.","journal-title":"Combination ciprofloxacin and metronidazole for active Crohn\u2019s disease. Can J Gastroenterol"},{"key":"e_1_2_1_142_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.935_q.x"},{"key":"e_1_2_1_143_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90121-3"},{"key":"e_1_2_1_144_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199310000-00013"},{"key":"e_1_2_1_145_1","first-page":"533","article-title":"Metronidazole therapy for Crohn\u2019s disease and associated fistulae","volume":"79","author":"Jakobovits J","year":"1984","unstructured":"Jakobovits J, Schuster MM. Metronidazole therapy for Crohn\u2019s disease and associated fistulae. Am J Gastroenterol 1984;79: 533\u201340.","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_1_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(82)80332-6"},{"key":"e_1_2_1_147_1","first-page":"571","article-title":"O\u2019Connor BI, Steinhart AH, Greenberg GR, Cohen Z","volume":"7","author":"Solomon MJ","year":"1993","unstructured":"Solomon MJ, McLeod RS, O\u2019Connor BI, Steinhart AH, Greenberg GR, Cohen Z. Combination ciprofloxacin and metronidazole in severe perianal Crohn\u2019s disease. Can J Gastroenterol 1993;7:571\u20133.","journal-title":"Combination ciprofloxacin and metronidazole in severe perianal Crohn\u2019s disease. Can J Gastroenterol"},{"key":"e_1_2_1_148_1","doi-asserted-by":"crossref","unstructured":"Geerling BJ Stockbrugger RW Brummer R-JM. Nutrition and inflammatory bowel disease: an update. Scand J Gastroenterol 1999; Suppl 230:95\u2013105.","DOI":"10.1080\/003655299750025615"},{"key":"e_1_2_1_149_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.29.10.1309"},{"key":"e_1_2_1_150_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.32.12.1492"},{"key":"e_1_2_1_151_1","first-page":"241","article-title":"State of the art concerning probiotic strains in milk products","volume":"5","author":"Schaafsma G","year":"1996","unstructured":"Schaafsma G. State of the art concerning probiotic strains in milk products. IDF Nutr Newsl 1996;5:241\u20135.","journal-title":"IDF Nutr Newsl"},{"key":"e_1_2_1_152_1","first-page":"2","article-title":"Ecological control of the gastrointestinal tract","volume":"42","author":"Bengmark S","year":"1998","unstructured":"Bengmark S. Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut 1998;42:2\u20137.","journal-title":"The role of probiotic flora. Gut"},{"key":"e_1_2_1_153_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00560.x"},{"key":"e_1_2_1_154_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.1999.tb01381.x"},{"key":"e_1_2_1_155_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00386.x"},{"key":"e_1_2_1_156_1","first-page":"1519","article-title":"Clostridium","author":"Gorbach SL","year":"1987","unstructured":"Gorbach SL, Chang T, Goldin B. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 1987;ii:1519.","journal-title":"difficile colitis with Lactobacillus GG. Lancet"},{"key":"e_1_2_1_157_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70029-6"},{"key":"e_1_2_1_158_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(99)00812-6"},{"key":"e_1_2_1_159_1","doi-asserted-by":"publisher","DOI":"10.1159\/000201045"},{"key":"e_1_2_1_160_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00225.x"},{"key":"e_1_2_1_161_1","first-page":"635","volume-title":"Escherichia coli","author":"Rembacken BJ","year":"1999","unstructured":"Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon ATR. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 1999;354: 635\u20139."},{"key":"e_1_2_1_162_1","doi-asserted-by":"crossref","unstructured":"Bennet JD Brinkman M. Treatment of ulcerative colitis with implantation of normal colonic flora. Lancet 1989;i:164.","DOI":"10.1016\/S0140-6736(89)91183-5"},{"key":"e_1_2_1_163_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)84011-0"},{"key":"e_1_2_1_164_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018876400528"},{"key":"e_1_2_1_165_1","doi-asserted-by":"publisher","DOI":"10.1159\/000177907"},{"key":"e_1_2_1_166_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/64.3.324"},{"key":"e_1_2_1_167_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90192-2"}],"container-title":["Scandinavian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/003655201753265082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T16:09:00Z","timestamp":1770912540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/003655201753265082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":166,"journal-issue":{"issue":"234","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["10.1080\/003655201753265082"],"URL":"https:\/\/doi.org\/10.1080\/003655201753265082","relation":{},"ISSN":["0036-5521","1502-7708"],"issn-type":[{"value":"0036-5521","type":"print"},{"value":"1502-7708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}